Mechanisms of drug resistance in leukemia cells.

Maria R. Baer, MD joined the University of Maryland Marlene and Stewart Greenebaum Cancer Center as Director of Hematologic Malignancies in April 2007. Since July 2014, she has been the Co-Leader of the University of Maryland Marlene and Stewart Greenebaum Cancer Center Experimental Therapeutics Program.

Dr. Baer is Professor of Medicine and Professor of Molecular Medicine at the University of Maryland School of Medicine. She previously served as Chief of the Leukemia Section of Roswell Park Cancer Institute and Professor of Medicine and Associate Professor of Molecular Pharmacology and Cancer Therapeutics at the University at Buffalo School of Medicine and Biomedical Sciences in Buffalo, New York.

Dr. Baer graduated magna cum laude from Harvard University and earned her medical degree from the Johns Hopkins University School of Medicine. She completed her residency in Medicine and fellowship in Hematology, and was a National Research Service trainee at Vanderbilt University. She has conducted and participated in numerous clinical trials in leukemia, myelodysplastic syndromes and myeloproliferative neoplasms. Her laboratory focuses on mechanisms of drug resistance in leukemia cells.